A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia. Am J Cardiovasc Drugs. 2010; 10(5):305-14.